• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » MassDevice.com +5 | The top 5 medtech stories for September 23, 2016

MassDevice.com +5 | The top 5 medtech stories for September 23, 2016

September 23, 2016 By MassDevice

plus5-node

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

Get this in your inbox everyday by subscribing to our newsletters.

 

5. Medtronic escapes Infuse lawsuits involving fugitive Ohio doc

MassDevice.com news

Medtronic yesterday escaped hundreds of lawsuits filed over the allegedly off-label use of its controversial bone-growth product, Infuse, by a Cincinnati doctor who has since fled to Pakistan.

Infuse consists of a collagen sponge that’s soaked in a bone-growth protein called recombinant human bone morphogenetic protein-2 and implanted in the spine within a metal device called the LT-Cage. The FDA approved Infuse in 2002 for use in single-level anterior lumbar interbody fusions (other dental and trauma indications followed). Read more


4. Draper Labs plans human study of neural implants

MassDevice.com news

Draper Laboratories is reportedly planning for the 1st human study of its neural implants for amputees to begin in late 2016 or early 2017.

This follows Phase I findings that demonstrated Draper’s wireless electronics package for its implantable devices work effectively by achieving a high bandwidth communication capacity of 20 megabits per second, relaying information quickly and efficiently. Read more


3. Staar Surgical wins Health Canada nod for Visian Toric ICL

MassDevice.com news

Staar Surgical said today it won approval from Health Canada’s Medical Devices Bureau for its Evo Visian Toric ICL intraocular lenses.

The Evo Visian Toric ICL is designed to be implanted inside the eye between the iris and the natural lens indefinitely to correct vision, Monrovia, Calif.-based Staar Surgical said. Read more


2. Medtronic touts low CD-TLR rates, strong durability in 3-year In.Pact Admiral DCB study

MassDevice.com news

Medtronic this week released data from 2 clinical studies evaluating its In.Pact Admiral drug-coated balloon for treating claudication and restenosis, touting sustained durability at 3-years.

Results were presented at the Vascular Interventional Advances 2016 conference in Las Vegas this week. Read more


1. Big Pharma urges acquittal for ex-Acclarent execs

MassDevice.com news

Pharmaceutical giants including Bayer and Pfizer filed a motion backing ex-Acclarent executives William Facteau and Patrick Fabian, urging the Massachusetts federal court to acquit them of their misdemeanor charges.

Former Acclarent CEO Facteau and ex-sales vice president Fabian were convicted in July on 10 misdemeanor counts of “introducing adulterated and misbranded medical devices into interstate commerce.” Earlier this month, Judge Allison Burroughs lifted the bail and travel restrictions that were imposed on the pair. Read more

Filed Under: News Well Tagged With: Plus 5

More recent news

  • Accelus wins FDA clearance for MRI compatibility of FlareHawk spinal implants
  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech
  • Neurent Medical wins FDA nod for next-gen chronic rhinitis treatment
  • Medtronic unveils “MiniMed” as name for soon-to-be separated Diabetes unit

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy